Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. JP 2021519305-A2021-08-10

    METHODS AND COMPOSITIONS FOR TARGETING LIVER AND LYMPH NODE SINUSOIDAL ENDOTHELIAL CELL C-TYPE LECTIN (LSECTIN)

    The University of Chicago

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 14 to 21. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   14 SIINFEKL 21
    

    8 of 8 identical, no gaps.

  2. US 11083751-B22021-08-10

    Tumor-associated dendritic cell preparations and uses thereof

    VIB VZW, Vrije Universiteit Brussel and Universiteit Gent

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. EP 3860647-A12021-08-11

    COMBINATION CELL-BASED THERAPIES

    HEAT BIOLOGICS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. EP 3866981-A12021-08-25

    METHODS FOR GENERATING THERAPEUTIC DELIVERY PLATFORMS

    UNIV KANSAS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  5. US 11104708-B22021-08-31

    Articles comprising a silk polypeptide for antigen delivery

    Amsilk GmbH, Ludwig-Maximilians-Universitat Munchen and Universitat Bayreuth

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 580 to 587. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   580 SIINFEKL 587
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  6. WO 2021172595-A2021-09-02

    ANTIGEN PRESENTING EXTRACELLUAR VESICLES, COMPOSITIONS COMPRISING THEREOF, AND METHODS FOR MANUFACTURING THEREOF

    NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY, NISSAN CHEMICAL CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  7. CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS

    VerImmune Inc

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  8. COMBINATION THERAPY FOR CANCER COMPRISING PD-1 AXIS BINDING ANTAGONIST AND IL6 ANTAGONIST

    GENENTECH INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  9. JP 2021524268-A2021-09-13

    ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137

    F-STAR BETA LIMITED

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, GB 1811405.8.

  10. HSD11B1 INHIBITORS FOR USE IN IMMUNOTHERAPY AND USES THEREOF

    UNIV GENEVE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. US 11123304-B22021-09-21

    Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles

    The Brigham and Women's Hospital, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. JP 2021525076-A2021-09-24

    SHARED ANTIGENS

    GRITSTONE ONCOLOGY INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/675559.

  13. WO 2021193900-A2021-09-30

    Immunity-inducing agent comprising polynucleotide-peptide conjugate and pharmaceutical composition comprising same

    THE UNIVERSITY OF KITAKYUSHU,DAIICHI SANKYO COMPANY LIMITED

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   2 SIINFEKL 9
    

    8 of 8 identical, no gaps.

  14. TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION

    BIONTECH SE

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  15. METHODS AND COMPOSITIONS

    ALLIGATOR BIOSCIENCE AB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  16. US 11141432-B22021-10-12

    Materials and methods for increasing immune responses

    Mayo Foundation for Medical Education and Research

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. EP 3892299-A12021-10-13

    IMMUNOSUPPRESSANT

    ONO PHARMACEUTICAL CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  18. US 11154597-B22021-10-26

    Sequence arrangements and sequences for neoepitope presentation

    NantCell, Inc., Nant Holdings IP, LLC and NantOmics, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 294 to 301. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   294 SIINFEKL 301
    

    8 of 8 identical, no gaps.

  19. WO 2021215462-A2021-10-28

    Improved peptide vaccines

    BrightPath Biotherapeutics Co Ltd,Kagoshima University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 5 to 12. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    5 SIINFEKL 12
    

    8 of 8 identical, no gaps.

  20. US 11162143-B22021-11-02

    Methods for generating therapeutic delivery platforms

    The University of Kansas and Kansas State University Research Foundation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. EP 3902530-A12021-11-03

    POLYMERIC NANOVACCINES AND USES THEREOF

    UNIV RAMOT

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  22. DELIVERY OF BIOMOLECULES TO PBMCS TO MODIFY AN IMMUNE RESPONSE

    SQZ BIOTECHNOLOGIES COMPANY

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  23. JP 2021530457-A2021-11-11

    METHODS AND COMPOSITIONS FOR REGULATING AN IMMUNE RESPONSE

    Board of Regents of the University of Texas System

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  24. JP 2021531266-A2021-11-18

    COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 4 to 11. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    4 SIINFEKL 11
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 62/697092.

  25. COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS

    LIFE SCIENCE INKUBATOR BETR GMBH & CO KG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  26. COMPOSITION OF NANOPARTICLES

    LIFE SCIENCE INKUBATOR BETR GMBH & CO KG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS

    LIFE SCIENCE INKUBATOR BETR GMBH & CO KG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. US 11179461-B22021-11-23

    Ii vaccine adjuvant

    UNIVERSITY OF COPENHAGEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  29. US 11186618-B22021-11-30

    Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide

    THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  30. JP 2021533134-A2021-12-02

    Adjuvant Effect of the TLR1/2 Agonist Diprovocim Synergizes with Checkpoint-Inhibiting Antibodies to Eliminate Disease

    University of Texas Southwestern Medical Center

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  31. US 11191821-B22021-12-07

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America as represented by the Secretary, Department of Health and Human Services

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 11192935-B22021-12-07

    PD-1-CD28 fusion proteins and their use in medicine

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  33. US 11198722-B22021-12-14

    Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use

    UNIVERSITY OF UTAH RESEARCH FOUNDATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  34. JP 2021534763-A2021-12-16

    MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS

    CLARA FOODS CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  35. US 11202823-B22021-12-21

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  36. US 11207418-B22021-12-28

    Synthetic nanoparticles for delivery of immunomodulatory compounds

    Massachusetts Institute of Technology

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  37. JP 2022501339-A2022-01-06

    RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY

    MEMORIAL SLOAN KETTERING CANCER CENTER

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  38. JP 2022502433-A2022-01-11

    TREATMENT METHODS

    GENOCEA BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  39. JP 2022502435-A2022-01-11

    TREATMENT METHODS

    GENOCEA BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. JP 2022506034-A2022-01-17

    Pharmaceutical compositions, vaccines and their uses in the prevention or treatment of a persistent infection or of cancer

    Universitatsmedizin der Johannes Gutenberg-Universitat Mainz

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  41. JP 2022507879-A2022-01-18

    Compounds

    Grey Wolf Therapeutics Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. US 11236166-B22022-02-01

    CD8 binding agents

    Orionis Biosciences BV, VIB VZW and UNIVERSITEIT GENT

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. JP 2022512762-A2022-02-07

    METHODS FOR GENERATING THERAPEUTIC DELIVERY PLATFORMS

    THE UNIVERSITY OF KANSAS,KANSAS STATE UNIVERSITY RESEARCH FOUNDATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  44. JP 2022512874-A2022-02-07

    MADRASIN-DERIVATIVE COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER

    INSTITUT GUSTAVE ROUSSY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  45. JP 2022512897-A2022-02-07

    TREATMENT METHODS

    GENOCEA BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  46. MODIFIED ADENOVIRUSES

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

    Family of 5

    Grouped by a shared priority claim, US 62/854865.

  47. US 11246924-B22022-02-15

    Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform

    Duke University and Emory University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  48. US 11246943-B22022-02-15

    Antigen-specific tolerance and compositions for induction of same

    Ecole Polytechnique Federale de Lausanne (EPFL)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

  49. US 11248264-B22022-02-15

    Individualized vaccines for cancer

    TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH and BioNTech SE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  50. JP 2022515473-A2022-02-18

    COMBINATION THERAPY USING A PEPTIDE-MHC-I-ANTIBODY FUSION PROTEIN

    F Hoffmann-La Roche AG,Robert Koch-Institut

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.